New Delhi, Mar 6 (PTI) Glenmark Life Sciences Ltd on Wednesday said its Chairman Glenn Saldanha and non-executive director VS Mani have resigned following change in ownership of the company.

Independent director Sridhar Gorthi has also tendered resignation, along with Saldanha and Mani, with effect from close of business hours on March 6, 2024, the company said in a regulatory filing.

Also Read | Gender Disparity: Only 1.6% of Companies Listed in Fortune India 500 Led by Women, Study Shows.

In his resignation letter shared on BSE by the company, Saldanha said his stepping down from the board and as chairman of the company is "pursuant to the transfer of ownership of the company by Glenmark Pharmaceuticals to Nirma Ltd".

He is also stepping down as a member of the nomination and remuneration committee and operations committee of Glenmark Life Sciences.

Also Read | BPSC Recruitment 2024: Vacancies Notified For Over 46,000 Posts on bpsc.bih.nic.in, Know How to Apply.

In September last year, Nirma Ltd had agreed to acquire 75 per cent stake in Glenmark Life Sciences for Rs 5,651.5 crore from Glenmark Pharmaceuticals.

Mani also cited a similar reason for his resignation.

On the other hand, Gorthi cited increasing professional commitments and "inability to devote the required time to discharge the role and responsibilities" for his resignation, while also stepping down from the membership of all the committees of the board.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)